SCHEMBL27363632

SCHEMBL27363632

Cc1ccc(N2CC(C3CN(C)C3)C2)nc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 5/20 0.48
HTR3A P46098 1/20 0.48
CHRNB4 P30926 1/20 0.48
CHRNA3 P32297 1/20 0.48
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2B Q13224 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
GPR119 Q8TDV5 1/20 0.44
CHRNB2 P17787 1/20 0.43
CHRNA4 P43681 1/20 0.43
PDE10A Q9Y233 1/20 0.42
DRD2 P14416 3/20 0.40
DRD1 P21728 3/20 0.40
DRD5 P21918 3/20 0.40
DRD3 P35462 3/20 0.40
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23843149 0.86 GRIN2D (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL27366420 0.83 GRIN2D (0.43) CHRNA7GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL27367308 0.82 GRIN2D (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL27364505 0.82 PDE10A (0.45) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL21588382 0.81 PDE10A (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL929461 0.81 CHRNA7 (0.47) CHRNA7HTR3ACHRNB4CHRNA3GRIN2D
SCHEMBL14845792 0.81 CHRNA7 (0.47) CHRNA7GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL10154595 0.80 GRIN2D (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL16472352 0.80 GRIN2D (0.49) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL14845793 0.79 PDE10A (0.50) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024054591-A1 RAPIDLY ACCELERATED FIBROSARCOMA (RAF) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-03-14 WO disclosed